Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Activating KIRs on Educated NK Cells Support Downregulation of CD226 and Inefficient Tumor Immunosurveillance.
Guillamón CF, Martínez-Sánchez MV, Gimeno L, Campillo JA, Server-Pastor G, Martínez-García J, Martínez-Escribano J, Torroba A, Ferri B, Abellán DJ, Legaz I, López-Álvarez MR, Moya-Quiles MR, Muro M, Minguela A. Guillamón CF, et al. Cancer Immunol Res. 2019 Aug;7(8):1307-1317. doi: 10.1158/2326-6066.CIR-18-0847. Epub 2019 Jun 25. Cancer Immunol Res. 2019. PMID: 31239317
NK Cell Education in Tumor Immune Surveillance: DNAM-1/KIR Receptor Ratios as Predictive Biomarkers for Solid Tumor Outcome.
Guillamón CF, Martínez-Sánchez MV, Gimeno L, Mrowiec A, Martínez-García J, Server-Pastor G, Martínez-Escribano J, Torroba A, Ferri B, Abellán D, Campillo JA, Legaz I, López-Álvarez MR, Moya-Quiles MR, Muro M, Minguela A. Guillamón CF, et al. Cancer Immunol Res. 2018 Dec;6(12):1537-1547. doi: 10.1158/2326-6066.CIR-18-0022. Epub 2018 Sep 21. Cancer Immunol Res. 2018. PMID: 30242020
Immunological Risk Stratification of Bladder Cancer Based on Peripheral Blood Natural Killer Cell Biomarkers.
Guillamón CF, Gimeno L, Server G, Martínez-Sánchez MV, Escudero JF, López-Cubillana P, Cabezas-Herrera J, Campillo JA, Abellan DJ, Martínez-García J, Martínez-Escribano J, Ferri B, López-Álvarez MR, Moreno-Alarcón C, Moya-Quiles MR, Muro M, Minguela A. Guillamón CF, et al. Eur Urol Oncol. 2021 Apr;4(2):246-255. doi: 10.1016/j.euo.2019.04.009. Epub 2019 May 14. Eur Urol Oncol. 2021. PMID: 31411976
KIR+ CD8+ T Lymphocytes in Cancer Immunosurveillance and Patient Survival: Gene Expression Profiling.
Gimeno L, Serrano-López EM, Campillo JA, Cánovas-Zapata MA, Acuña OS, García-Cózar F, Martínez-Sánchez MV, Martínez-Hernández MD, Soto-Ramírez MF, López-Cubillana P, Martínez-Escribano J, Martínez-García J, Corbalan-García S, Álvarez-López MR, Minguela A. Gimeno L, et al. Cancers (Basel). 2020 Oct 15;12(10):2991. doi: 10.3390/cancers12102991. Cancers (Basel). 2020. PMID: 33076479 Free PMC article.
CD8+ T lymphocytes are sensitive to NKG2A/HLA-E licensing interaction: role in the survival of cancer patients.
Gimeno L, González-Lozano I, Soto-Ramírez MF, Martínez-Sánchez MV, López-Cubillana P, Fuster JL, Martínez-García J, Martínez-Escribano J, Campillo JA, Pons-Fuster E, Ferri B, López-Abad A, Muro M, Minguela A. Gimeno L, et al. Oncoimmunology. 2021 Oct 14;10(1):1986943. doi: 10.1080/2162402X.2021.1986943. eCollection 2021. Oncoimmunology. 2021. PMID: 34676148 Free PMC article.
A nomogram for predicting complications in patients with solid tumours and seemingly stable febrile neutropenia.
Fonseca PJ, Carmona-Bayonas A, García IM, Marcos R, Castañón E, Antonio M, Font C, Biosca M, Blasco A, Lozano R, Ramchandani A, Beato C, de Castro EM, Espinosa J, Martínez-García J, Ghanem I, Cubero JH, Manrique IA, Navalón FG, Sevillano E, Manzano A, Virizuela J, Garrido M, Mondéjar R, Arcusa MÁ, Bonilla Y, Pérez Q, Gallardo E, Del Carmen Soriano M, Cardona M, Lasheras FS, Cruz JJ, Ayala F. Fonseca PJ, et al. Br J Cancer. 2016 May 24;114(11):1191-8. doi: 10.1038/bjc.2016.118. Epub 2016 May 17. Br J Cancer. 2016. PMID: 27187687 Free PMC article.
Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin (pld) in a real-world setting: a geico study.
Rubio MJ, Manzano A, de Sande LM, Estévez-García P, Gordon MDM, de Prado DS, de Aranguiz BHF, Guerra-Alia EM, Carbó-Bagué A, Romero I, Corbellas M, González-Haba A, Robles-Barraza CE, Martínez-García J, González-Martín A. Rubio MJ, et al. BMC Cancer. 2024 Jul 5;24(1):803. doi: 10.1186/s12885-024-12577-z. BMC Cancer. 2024. PMID: 38970024 Free PMC article.
A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study.
Martínez-Trufero J, De Sande-González LM, Luna P, Martin-Broto J, Álvarez R, Marquina G, Diaz-Beveridge R, Poveda A, Cano JM, Cruz-Jurado J, López Pousa A, Vaz Salgado MA, Valverde-Morales CM, Sevilla I, Martínez-García J, Rubio-Casadevall J, De Juan A, Carrasco JA, Moura DS, Gurruchaga-Sotes I, Gutiérrez A. Martínez-Trufero J, et al. Cancers (Basel). 2021 Feb 14;13(4):792. doi: 10.3390/cancers13040792. Cancers (Basel). 2021. PMID: 33672857 Free PMC article.
Bacteremia in adult cancer patients with apparently stable febrile neutropenia: data from a cohort of 692 consecutive episodes from a single institution.
Carmona-Bayonas A, Fonseca PJ, Font C, Martínez-García J, Torrella F, Urrego E, Castaño P, Navarrete A, Antonio-Rebolla M, Gómez JG, Vincente V, Ayala F. Carmona-Bayonas A, et al. J Community Support Oncol. 2014 Sep;12(9):312-20. doi: 10.12788/jcso.0071. J Community Support Oncol. 2014. PMID: 25848908
210 results